Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors

<p>Glioblastoma patient characteristics (DFCI)</p>

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Joseph Toker (15399882) (author)
Awduron Eraill: J. Bryan Iorgulescu (15030477) (author), Alexander L. Ling (15399885) (author), Genaro R. Villa (15399888) (author), Josephina A.M.A. Gadet (15399891) (author), Laxmi Parida (15112564) (author), Gad Getz (14945542) (author), Catherine J. Wu (14944480) (author), David A. Reardon (15043854) (author), E. Antonio Chiocca (15399894) (author), Marco Mineo (15399897) (author)
Cyhoeddwyd: 2025
Pynciau:
Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Biomarkers
CNS Cancers
Gliomas, Glioblastomas
Immunotherapy
Checkpoint blockade
Skin Cancers
Melanoma
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
Disgrifiad
Crynodeb:<p>Glioblastoma patient characteristics (DFCI)</p>

Eitemau Tebyg